Regeneron Pharmaceuticals (REGN)
Stockholders Equity
$31.71B
Quarterly · Period ending: · USD
REGN Stockholders Equity
Latest reported$31.71Bperiod ending
Latest reported$31.71Bperiod ending
REGN Quarterly Shareholders Equity ($12.20M → $31.71B)
Quarterly shareholders equity
High-resolution chart · PNG
REGN stockholders equity history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 313,294,000 | |
| 324,411,000 | |
| 182,130,000 | |
| 190,972,000 | |
| 175,971,000 | |
| 105,595,000 | |
| 109,500,000 | |
| 110,500,000 | |
| 115,400,000 | |
| 123,400,000 | |
| 131,200,000 | |
| 136,900,000 | |
| 137,800,000 | |
| 135,400,000 | |
| 138,900,000 | |
| 138,200,000 | |
| 139,900,000 | |
| 101,000,000 | |
| 106,900,000 | |
| 104,200,000 | |
| 112,800,000 | |
| 62,100,000 | |
| 67,900,000 | |
| 53,000,000 | |
| 59,400,000 | |
| 63,800,000 | |
| 67,100,000 | |
| 72,800,000 | |
| 76,600,000 | |
| 86,700,000 | |
| 98,400,000 | |
| 110,100,000 | |
| 68,400,000 | |
| 77,800,000 | |
| 87,200,000 | |
| 93,500,000 | |
| 99,300,000 | |
| 103,000,000 | |
| 106,200,000 | |
| 108,400,000 | |
| 109,300,000 | |
| 12,200,000 |